{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:52:18Z","timestamp":1789447938982,"version":"build-2803163510"},"reference-count":70,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"Gr\u00fcnenthal GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Manage."],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.2217\/pmt.12.22","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T13:15:20Z","timestamp":1343913320000},"page":"351-362","source":"Crossref","is-referenced-by-count":14,"title":["Systematic Review of Adverse Events of Buprenorphine Patch Versus Fentanyl Patch in Patients with Chronic Moderate-To-Severe Pain"],"prefix":"10.1080","volume":"2","author":[{"given":"Robert F","family":"Wolff","sequence":"first","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Reid","sequence":"additional","affiliation":[{"name":"KJResearch, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"di Nisio","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SS. ma Annunziata Hospital, Chieti Scalo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagfinn","family":"Aune","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Truyers","sequence":"additional","affiliation":[{"name":"Department of General Practice, Katholieke Universiteit Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD, UK"},{"name":"Health Outcomes & Clinical Epidemiology, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Misso","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Riemsma","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Kleijnen","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd, Unit 6, Escrick Business Park, Riccall Road, Escrick, York, YO19 6FD, UK"},{"name":"Care & Public Health Research Institute (CAPHRI), Maastricht University, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,8,2]]},"reference":[{"key":"e_1_3_4_3_1_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.545813"},{"key":"e_1_3_4_3_2_1","unstructured":"Opioids in Cancer Pain . Davis M Glare P Hardy J (Eds). Oxford University Press Oxford UK (2005)."},{"key":"e_1_3_4_3_3_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.586332"},{"issue":"1","key":"e_1_3_4_3_4_1","first-page":"1","volume":"11","author":"Macdiarmid SA","year":"2009","unstructured":"Macdiarmid SA . The evolution of transdermal\/topical overactive bladder therapy and its benefits over oral therapy. Rev Urol.11(1) , 1\u20136 (2009).","journal-title":"Rev Urol."},{"key":"e_1_3_4_3_5_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X233403"},{"key":"e_1_3_4_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.11.008"},{"key":"e_1_3_4_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00378.x"},{"key":"e_1_3_4_3_8_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.678938"},{"key":"e_1_3_4_3_9_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.611494"},{"key":"e_1_3_4_3_10_1","unstructured":"Allan L KalsoE. Randomized trial of transdermal fentanyl and sustained release oral morphine in chronic low back pain. Presented at: Pain in Europe IV. Fourth Congress of the European Federation of IASP Chapters (EFIC) . Prague Czech Republic 2\u20136 September 2003."},{"key":"e_1_3_4_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000186860.23078.a8"},{"key":"e_1_3_4_3_12_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K066"},{"key":"e_1_3_4_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1090-3801(98)90046-5"},{"key":"e_1_3_4_3_14_1","first-page":"177","volume":"5","author":"Kongsgaard UE","year":"1997","unstructured":"Kongsgaard UE , PoulainP. Transdermal fentanyl for pain control in chronic cancer pain. Support Care Cancer5(Suppl. 1) , 177 (1997).","journal-title":"Support Care Cancer"},{"key":"e_1_3_4_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.10.023"},{"key":"e_1_3_4_3_16_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1808-18512009000400016"},{"key":"e_1_3_4_3_17_1","doi-asserted-by":"publisher","DOI":"10.1385\/IJGC:27:3:235"},{"key":"e_1_3_4_3_18_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125002045"},{"key":"e_1_3_4_3_19_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X53315"},{"key":"e_1_3_4_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21884"},{"key":"e_1_3_4_3_21_1","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.53.23"},{"key":"e_1_3_4_3_22_1","doi-asserted-by":"publisher","DOI":"10.1191\/026921601678320296"},{"key":"e_1_3_4_3_23_1","doi-asserted-by":"crossref","unstructured":"Sarhan T DoghemM. A comparison of two trans-dermal drug delivery systems; buprenorphine and fentanyl for chronic cancer pain management. Presented at: Pain in Europe VI: Sixth Congress of the European Federation of IASP Chapters (EFIC) . Lisbon Portugal 9\u201312 September 2009.","DOI":"10.1016\/S1090-3801(09)60693-5"},{"key":"e_1_3_4_3_24_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X89829"},{"key":"e_1_3_4_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)90019-1"},{"key":"e_1_3_4_3_26_1","first-page":"142","volume":"150","author":"Tschirner M","year":"2008","unstructured":"Tschirner M , RitzdorfI, BrunjesR. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain]. MMW Fortschr. Med.150(Suppl. 3) , 142\u2013148 (2008).","journal-title":"MMW Fortschr. Med."},{"key":"e_1_3_4_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.10.003"},{"key":"e_1_3_4_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2003.12.003"},{"key":"e_1_3_4_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.01.006"},{"issue":"5","key":"e_1_3_4_3_30_1","volume":"15","author":"Muriel Villoria C","year":"2008","unstructured":"Muriel Villoria C , Cervera Grau JM, Constela Figueras M, Sanchez Magro I, Neira Alvarez M. [Evaluation of transdermal buprenorphine for the treatment of chronic pain in cancer patients]. Revista de la Sociedad Espanola del Dolor15(5) (2008).","journal-title":"Revista de la Sociedad Espanola del Dolor"},{"key":"e_1_3_4_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.04.007"},{"key":"e_1_3_4_3_32_1","doi-asserted-by":"publisher","DOI":"10.1157\/13098717"},{"issue":"3","key":"e_1_3_4_3_33_1","first-page":"20","volume":"20","author":"Ozturk T","year":"2008","unstructured":"Ozturk T , KaradibakK, CatalD, CakanA, TugsavulF, CirakK. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer]. Agri. Derg.20(3) , 20\u201325 (2008).","journal-title":"Agri. Derg."},{"key":"e_1_3_4_3_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181a38f9d"},{"key":"e_1_3_4_3_35_1","first-page":"445","volume":"71","author":"Aurilio B","year":"2005","unstructured":"Aurilio B , PaceMC, PassavantiMB. Transdermal buprenorphine combined with spinal morphine and naropine for pain relief in chronic peripheral vasculopathy. Minerva Anestesiol.71(7\u20138) , 445\u2013449 (2005).","journal-title":"Minerva Anestesiol."},{"key":"e_1_3_4_3_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181673b65"},{"key":"e_1_3_4_3_37_1","doi-asserted-by":"publisher","DOI":"10.2741\/2147"},{"key":"e_1_3_4_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.09.011"},{"issue":"1","key":"e_1_3_4_3_39_1","first-page":"25","volume":"35","author":"Wong JO","year":"1997","unstructured":"Wong JO , ChiuGL, TsaoCJ, ChangCL. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol. Sin.35(1) , 25\u201332 (1997).","journal-title":"Acta Anaesthesiol. Sin."},{"key":"e_1_3_4_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00205.x"},{"key":"e_1_3_4_3_41_1","first-page":"171","volume":"13","author":"Zuurmond W","year":"2002","unstructured":"Zuurmond W , DavisC, VergidisD. Transdermal fentanyl shows a similar safety and efficacy profile in elderly and non-elderly patients with cancer pain. Ann. Oncol.13(Suppl. 5) , 171 (2002) (Abstract 630).","journal-title":"Ann. Oncol."},{"key":"e_1_3_4_3_42_1","first-page":"377a","volume":"21","author":"Zuurmond W","year":"2002","unstructured":"Zuurmond W , DavisC. Safety and efficacy of transdermal fentanyl (Durogesic) compared with sustained-release morphine in patients with cancer pain. Proc. Am. Soc. Clin. Oncol.21(Pt 1) , 377a (2002) (Abstract 1506).","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"e_1_3_4_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.SMJ.0000109215.54052.D8"},{"key":"e_1_3_4_3_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7295.1154"},{"key":"e_1_3_4_3_45_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D109"},{"key":"e_1_3_4_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)96123-U"},{"key":"e_1_3_4_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00082-1"},{"key":"e_1_3_4_3_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-28-61"},{"key":"e_1_3_4_3_49_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000281078.65585.1e"},{"key":"e_1_3_4_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.12.001"},{"key":"e_1_3_4_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.06.030"},{"issue":"2","key":"e_1_3_4_3_52_1","first-page":"46","volume":"7","author":"Mordarski S","year":"2009","unstructured":"Mordarski S . Efficacy and safety of buprenorphine in patients receiving haemodialysis. J. Appl. Ther. Res.7(2) , 46\u201351 (2009).","journal-title":"J. Appl. Ther. Res."},{"key":"e_1_3_4_3_53_1","first-page":"3","volume":"14","author":"Budd K","year":"2002","unstructured":"Budd K . Immunosuppressive effects induced by opioid analgesics. Int. Monit. Regional Anaesthesia Pain Manage.14 , 3\u20137 (2002).","journal-title":"Int. Monit. Regional Anaesthesia Pain Manage."},{"key":"e_1_3_4_3_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/J354v21n01_15"},{"key":"e_1_3_4_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.07.005"},{"key":"e_1_3_4_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3015(10)69062-6"},{"key":"e_1_3_4_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2008.04.011"},{"key":"e_1_3_4_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2008.00204.x"},{"issue":"2","key":"e_1_3_4_3_59_1","first-page":"111","volume":"2","author":"Pergolizzi J","year":"2009","unstructured":"Pergolizzi J r JV. The use of high-dose transdermal buprenorphine in the treatment of cancer pain. J. Med.2(2) , 111\u2013120 (2009).","journal-title":"J. Med."},{"key":"e_1_3_4_3_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei145"},{"issue":"1","key":"e_1_3_4_3_61_1","first-page":"152","volume":"62","author":"Likar R","year":"2008","unstructured":"Likar R , KrainerB, SittlR. Challenging the equipotency calculation for transdermal buprenorphine: four case studies. Int. J. Cancer62(1) , 152\u2013156 (2008).","journal-title":"Int. J. Cancer"},{"key":"e_1_3_4_3_62_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000145066.06538.20"},{"key":"e_1_3_4_3_63_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990902920731"},{"key":"e_1_3_4_3_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2007.00119.x"},{"key":"e_1_3_4_3_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000251"},{"key":"e_1_3_4_4_2_1","unstructured":"WHO. WHO\u2018s pain ladder. www.who.int\/cancer\/palliative\/painladder\/en\/"},{"key":"e_1_3_4_4_3_1","unstructured":"Joint Formulary Committee. British National Formulary (2010). www.bnf.org\/bnf\/index.htm"},{"key":"e_1_3_4_4_4_1","unstructured":"Medsafe. New Zealand Medicines and Medical Devices Safety Authority. DBL RRR Fentanyl (2008). www.medsafe.govt.nz\/profs\/datasheet\/d\/dblfentanylinj.pdf"},{"key":"e_1_3_4_4_5_1","unstructured":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Higgins JPT Green S (Eds). The Cochrane Collaboration (2011). www.cochrane-handbook.org"},{"key":"e_1_3_4_4_6_1","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews: CRD\u2018s guidance for undertaking reviews in health care. University of York UK (2009). www.york.ac.uk\/inst\/crd\/SysRev\/!SSL!\/WebHelp\/SysRev3.htm"}],"container-title":["Pain Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pmt.12.22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:07:18Z","timestamp":1715944038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pmt.12.22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.2217\/pmt.12.22"],"URL":"https:\/\/doi.org\/10.2217\/pmt.12.22","relation":{},"ISSN":["1758-1869","1758-1877"],"issn-type":[{"value":"1758-1869","type":"print"},{"value":"1758-1877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}